Showing results (1541-1550 of 1,656) with videos related to

Sort By:
Pageof 166
Haematologica|April 27, 2023
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomesCharlotte B Wagner, Ken Boucher, Adrienne Nedved, et al.
Nature Immunology|May 15, 2012
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activationHaifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
Archives of Disease in Childhood|October 4, 2018
Research priorities for childhood chronic conditions: a workshop reportPamela Lopez-Vargas, Allison Tong, Sally Crowe, et al.
Nature Reviews. Molecular Cell Biology|January 3, 2023
Long non-coding RNAs: definitions, functions, challenges and recommendationsJohn S Mattick, Paulo P Amaral, Piero Carninci, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signalingAnne Louise Hansen, Gregory J Buchan, Michael Rühl, et al.
Blood Advances|February 26, 2026
Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort StudyJohn Sharp, Paolo Strati, Subodh Bhatta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2022
REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis RiskJaveed A Shah, Alex J Warr, Andrew D Graustein, et al.
Cell|November 5, 2024
Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repairKautilya K Jena, Julien Mambu, Daniel Boehmer, et al.
Blood Advances|November 7, 2025
Outcomes for CART as 2L vs 3L vs 4L or Beyond in Aggressive B-cell Lymphoma: Real World Evidence from the ABC ConsortiumJohn Seng Wang, Brandon Lee Ellsworth, Megan Melody, et al.
Nature Communications|August 31, 2018
Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogrammingDavid Olagnier, Aske M Brandtoft, Camilla Gunderstofte, et al.
Pageof 166